Global Cystic Fibrosis Therapeutics Market Size, Status and Forecast 2022

Publisher Name :
Date: 11-Dec-2017
No. of pages: 100
Inquire Before Buying

This report studies the global Cystic Fibrosis Therapeutics market, analyzes and researches the Cystic Fibrosis Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

- AbbVie

- Novartis

- F. Hoffmann-La Roche

- Vertex Pharmaceuticals

- Gilead Sciences

- AstraZeneca

- Bayer

- Advanced Inhalation Therapies

- Cyclacel Pharmaceuticals

- Kamada

- Nivalis Therapeutics

- Allergan

- Anthera Pharmaceuticals

- Chiesi Farmaceutici S.p.A.

- ProQR Therapeutics

- PTC Therapeutics

- Savara

- Parion Sciences

- Pharmaxis

- Vectura Group

Market segment by Regions/Countries, this report covers

- United States

- EU

- Japan

- China

- India

- Southeast Asia

Market segment by Type, the product can be split into

- Small Molecules

- Biologics

Market segment by Application, Cystic Fibrosis Therapeutics can be split into

- Hospitals

- Clinics

- Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Cystic Fibrosis Therapeutics Market Size, Status and Forecast 2022

Table of Contents
Global Cystic Fibrosis Therapeutics Market Size, Status and Forecast 2022
1 Industry Overview of Cystic Fibrosis Therapeutics
1.1 Cystic Fibrosis Therapeutics Market Overview
1.1.1 Cystic Fibrosis Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Cystic Fibrosis Therapeutics Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Cystic Fibrosis Therapeutics Market by Type
1.3.1 Small Molecules
1.3.2 Biologics
1.4 Cystic Fibrosis Therapeutics Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Other
2 Global Cystic Fibrosis Therapeutics Competition Analysis by Players
2.1 Cystic Fibrosis Therapeutics Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 AbbVie
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Novartis
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 F. Hoffmann-La Roche
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Vertex Pharmaceuticals
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Gilead Sciences
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 AstraZeneca
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Bayer
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Advanced Inhalation Therapies
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Cyclacel Pharmaceuticals
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Kamada
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Cystic Fibrosis Therapeutics Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Nivalis Therapeutics
3.12 Allergan
3.13 Anthera Pharmaceuticals
3.14 Chiesi Farmaceutici S.p.A.
3.15 ProQR Therapeutics
3.16 PTC Therapeutics
3.17 Savara
3.18 Parion Sciences
3.19 Pharmaxis
3.20 Vectura Group
4 Global Cystic Fibrosis Therapeutics Market Size by Type and Application (2012-2017)
4.1 Global Cystic Fibrosis Therapeutics Market Size by Type (2012-2017)
4.2 Global Cystic Fibrosis Therapeutics Market Size by Application (2012-2017)
4.3 Potential Application of Cystic Fibrosis Therapeutics in Future
4.4 Top Consumer/End Users of Cystic Fibrosis Therapeutics
5 United States Cystic Fibrosis Therapeutics Development Status and Outlook
5.1 United States Cystic Fibrosis Therapeutics Market Size (2012-2017)
5.2 United States Cystic Fibrosis Therapeutics Market Size and Market Share by Players (2016 and 2017)
6 EU Cystic Fibrosis Therapeutics Development Status and Outlook
6.1 EU Cystic Fibrosis Therapeutics Market Size (2012-2017)
6.2 EU Cystic Fibrosis Therapeutics Market Size and Market Share by Players (2016 and 2017)
7 Japan Cystic Fibrosis Therapeutics Development Status and Outlook
7.1 Japan Cystic Fibrosis Therapeutics Market Size (2012-2017)
7.2 Japan Cystic Fibrosis Therapeutics Market Size and Market Share by Players (2016 and 2017)
8 China Cystic Fibrosis Therapeutics Development Status and Outlook
8.1 China Cystic Fibrosis Therapeutics Market Size (2012-2017)
8.2 China Cystic Fibrosis Therapeutics Market Size and Market Share by Players (2016 and 2017)
9 India Cystic Fibrosis Therapeutics Development Status and Outlook
9.1 India Cystic Fibrosis Therapeutics Market Size (2012-2017)
9.2 India Cystic Fibrosis Therapeutics Market Size and Market Share by Players (2016 and 2017)
10 Southeast Asia Cystic Fibrosis Therapeutics Development Status and Outlook
10.1 Southeast Asia Cystic Fibrosis Therapeutics Market Size (2012-2017)
10.2 Southeast Asia Cystic Fibrosis Therapeutics Market Size and Market Share by Players (2016 and 2017)
11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Cystic Fibrosis Therapeutics Market Size (Value) by Regions (2017-2022)
11.1.1 United States Cystic Fibrosis Therapeutics Revenue and Growth Rate (2017-2022)
11.1.2 EU Cystic Fibrosis Therapeutics Revenue and Growth Rate (2017-2022)
11.1.3 Japan Cystic Fibrosis Therapeutics Revenue and Growth Rate (2017-2022)
11.1.4 China Cystic Fibrosis Therapeutics Revenue and Growth Rate (2017-2022)
11.1.5 India Cystic Fibrosis Therapeutics Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Cystic Fibrosis Therapeutics Revenue and Growth Rate (2017-2022)
11.2 Global Cystic Fibrosis Therapeutics Market Size (Value) by Type (2017-2022)
11.3 Global Cystic Fibrosis Therapeutics Market Size by Application (2017-2022)
12 Cystic Fibrosis Therapeutics Market Dynamics
12.1 Cystic Fibrosis Therapeutics Market Opportunities
12.2 Cystic Fibrosis Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Cystic Fibrosis Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Cystic Fibrosis Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Cystic Fibrosis Therapeutics Product Scope
Figure Global Cystic Fibrosis Therapeutics Market Size (Million USD) (2012-2017)
Table Global Cystic Fibrosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Cystic Fibrosis Therapeutics Market Share by Regions in 2016
Figure United States Cystic Fibrosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Cystic Fibrosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Cystic Fibrosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Cystic Fibrosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Cystic Fibrosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Cystic Fibrosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Cystic Fibrosis Therapeutics Market Share by Type in 2016
Figure Small Molecules Market Size (Million USD) and Growth Rate (2012-2017)
Figure Biologics Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Cystic Fibrosis Therapeutics Market Share by Application in 2016
Table Key Downstream Customer in Hospitals
Figure Cystic Fibrosis Therapeutics Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
Table Key Downstream Customer in Clinics
Figure Cystic Fibrosis Therapeutics Market Size (Million USD) and Growth Rate in Clinics (2012-2017)
Table Key Downstream Customer in Other
Figure Cystic Fibrosis Therapeutics Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Cystic Fibrosis Therapeutics Market Size (Million USD) by Players (2016 and 2017)
Figure Cystic Fibrosis Therapeutics Market Size Share by Players in 2016
Figure Cystic Fibrosis Therapeutics Market Size Share by Players in 2017
Table AbbVie Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of AbbVie (2012-2017)
Figure AbbVie Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table F. Hoffmann-La Roche Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of F. Hoffmann-La Roche (2012-2017)
Figure F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table Vertex Pharmaceuticals Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of Vertex Pharmaceuticals (2012-2017)
Figure Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table Gilead Sciences Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of Gilead Sciences (2012-2017)
Figure Gilead Sciences Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table AstraZeneca Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table Bayer Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of Bayer (2012-2017)
Figure Bayer Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table Advanced Inhalation Therapies Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of Advanced Inhalation Therapies (2012-2017)
Figure Advanced Inhalation Therapies Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table Cyclacel Pharmaceuticals Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of Cyclacel Pharmaceuticals (2012-2017)
Figure Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table Kamada Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of Kamada (2012-2017)
Figure Kamada Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table Nivalis Therapeutics Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of Nivalis Therapeutics (2012-2017)
Figure Nivalis Therapeutics Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table Allergan Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of Allergan (2012-2017)
Figure Allergan Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table Anthera Pharmaceuticals Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of Anthera Pharmaceuticals (2012-2017)
Figure Anthera Pharmaceuticals Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table Chiesi Farmaceutici S.p.A. Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of Chiesi Farmaceutici S.p.A. (2012-2017)
Figure Chiesi Farmaceutici S.p.A. Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table ProQR Therapeutics Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of ProQR Therapeutics (2012-2017)
Figure ProQR Therapeutics Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table PTC Therapeutics Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of PTC Therapeutics (2012-2017)
Figure PTC Therapeutics Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table Savara Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of Savara (2012-2017)
Figure Savara Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table Parion Sciences Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of Parion Sciences (2012-2017)
Figure Parion Sciences Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table Pharmaxis Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of Pharmaxis (2012-2017)
Figure Pharmaxis Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table Vectura Group Basic Information List
Table Cystic Fibrosis Therapeutics Business Revenue (Million USD) of Vectura Group (2012-2017)
Figure Vectura Group Cystic Fibrosis Therapeutics Business Revenue Market Share in 2016
Table Global Cystic Fibrosis Therapeutics Market Size (Million USD) by Type (2012-2017)
Figure Global Cystic Fibrosis Therapeutics Market Size Share by Type in 2012
Figure Global Cystic Fibrosis Therapeutics Market Size Share by Type in 2013
Figure Global Cystic Fibrosis Therapeutics Market Size Share by Type in 2014
Figure Global Cystic Fibrosis Therapeutics Market Size Share by Type in 2015
Figure Global Cystic Fibrosis Therapeutics Market Size Share by Type in 2016
Figure Global Cystic Fibrosis Therapeutics Market Size Share by Type in 2017
Table Global Cystic Fibrosis Therapeutics Market Size (Million USD) by Application (2012-2017)
Figure Global Cystic Fibrosis Therapeutics Market Size (Million USD) by Application in 2012
Figure Global Cystic Fibrosis Therapeutics Market Size (Million USD) by Application in 2013
Figure Global Cystic Fibrosis Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Cystic Fibrosis Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Cystic Fibrosis Therapeutics Market Size (Million USD) by Application in 2016
Figure Global Cystic Fibrosis Therapeutics Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Cystic Fibrosis Therapeutics
Figure United States Cystic Fibrosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Cystic Fibrosis Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure United States Cystic Fibrosis Therapeutics Market Size Share by Players in 2016
Figure United States Cystic Fibrosis Therapeutics Market Size Share by Players in 2017
Figure EU Cystic Fibrosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Cystic Fibrosis Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure EU Cystic Fibrosis Therapeutics Market Size Share by Players in 2016
Figure EU Cystic Fibrosis Therapeutics Market Size Share by Players in 2017
Figure Japan Cystic Fibrosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Cystic Fibrosis Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Japan Cystic Fibrosis Therapeutics Market Size Share by Players in 2016
Figure Japan Cystic Fibrosis Therapeutics Market Size Share by Players in 2017
Figure China Cystic Fibrosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Cystic Fibrosis Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure China Cystic Fibrosis Therapeutics Market Size Share by Players in 2016
Figure China Cystic Fibrosis Therapeutics Market Size Share by Players in 2017
Figure India Cystic Fibrosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Cystic Fibrosis Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure India Cystic Fibrosis Therapeutics Market Size Share by Players in 2016
Figure India Cystic Fibrosis Therapeutics Market Size Share by Players in 2017
Figure Southeast Asia Cystic Fibrosis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Cystic Fibrosis Therapeutics Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Cystic Fibrosis Therapeutics Market Size Share by Players in 2016
Figure Southeast Asia Cystic Fibrosis Therapeutics Market Size Share by Players in 2017
Figure Global Cystic Fibrosis Therapeutics Market Size (Million USD) by Regions (2017-2022)
Table Global Cystic Fibrosis Therapeutics Market Size (Million USD) by Regions (2017-2022)
Figure Global Cystic Fibrosis Therapeutics Market Size Share by Regions in 2017
Figure Global Cystic Fibrosis Therapeutics Market Size Share by Regions in 2022
Figure United States Cystic Fibrosis Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Cystic Fibrosis Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Cystic Fibrosis Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Cystic Fibrosis Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Cystic Fibrosis Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Cystic Fibrosis Therapeutics Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Cystic Fibrosis Therapeutics Market Size (Million USD) by Type (2017-2022)
Figure Global Cystic Fibrosis Therapeutics Market Size Share by Type in 2017
Figure Global Cystic Fibrosis Therapeutics Market Size Share by Type in 2022
Table Global Cystic Fibrosis Therapeutics Market Size (Million USD) by Application (2017-2022)
Figure Global Cystic Fibrosis Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Cystic Fibrosis Therapeutics Market Size (Million USD) by Application in 2022
  • Global Pizotifen Market Research Report 2018
    Published: 18-Jul-2018        Price: US 2900 Onwards        Pages: 99
    This report studies the global Pizotifen market status and forecast, categorizes the global Pizotifen market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Pizotifen market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The major manufacturer......
  • Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 35
    Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) pipel......
  • Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 37
    Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H2 2018 Summary Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Transglutaminase 2 (TG2) is a member of the transglutaminase family tha......
  • Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 40
    Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2018 Summary Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Respiratory syncytial virus G protein is a protein produced by respiratory syncytial virus. It attaches the virion to the host cell membrane by interacting with heparan sulfate. It interacts with host CX3CR1, the receptor for the CX3C chemokine fractalkine, to modulate the immune response and facilitate in......
  • Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 70
    Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H2 2018 Summary Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) pipeline Target constitutes close to 15 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes. The latest report Survival Motor Neuron Protein - Pipeline Review, H2 2018, outlays comprehensive information on the S......
  • NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 65
    NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'NT 3 Growth Factor Receptor - Pipeline Review, H2 2018'; NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) pipeline Target constitutes close to 7 molecules. ......
  • MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 41
    MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - MAP kinase-interacting serine/threonine-protein kinase 2 is an enzyme encoded by the MKNK2 gene. It phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. It plays a role in the response to environmental ......
  • BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 129
    BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'BDNF NT 3 Growth Factors Receptor - Pipeline Review, H2 2018'; BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK......
  • Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 48
    Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'Ephrin Type B Receptor 4 - Pipeline Review, H2 2018'; Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constitutes close to 6 molecules. Out of which approximately 3 molecules are developed by compa......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs